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and telomere shortening. Escape from apoptosis also makes cancer cells resistant to 
chemotherapy and radiation. The molecular machinery of apoptosis is a potential 
target for drugs that could promote cell death in colorectal cancer cells. The intrin-
sic (mitochondrial) pathway of apoptosis is regulated mainly the the Bcl-2 protein 
family, which are activated by various stimuli, including growth factor withdrawal 
and cellular damage. Under such circumstances, the antiapoptotic factors (eg. Bcl-2, 
Bcl-XL, Bcl-W, Mcl-1) release the proapoptotic factors (eg. BAK, BAX), which in turn 
increase mitochondrial membrane permeability, leading to cytochrome C release 
and Caspase 9 activation and consequently, via Caspase 3 activation, to apoptosis. 
In cancer antiapoptotic Bcl-2 family members are overexpressed, while the proap-
optotic factors are underexpressed. “BH-3 mimetics” are a class of small molecules 
inhibitors of certain antiapoptotic Bcl-2 family members. Navitoclax is a potent in-
hibitor of Bcl-2, Bcl-W and Bcl-XL, with in vitro evidence of apoptosis induction in 
colorectal cancer cells, and demonstrated safety in a phase I clinical trial in combina-
tion with established therapy regimes. Obatoclax is a promising pan-Bcl-2 inhibitor. 
HA14-1 is a small molecule selectively targeting Bcl-2. Oblimersen is an antisense 
oligonucleotide targeting Bcl-2, and has shown safety in phase I trials. In summary, 
several new drugs focusing on apoptosis induction in colorectal cancer are current-
ly being studied, which will hopefully lead to better therapies in the future.
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Emperipolesis means active penetration of one cell by another which remains 
intact. Main cells participating in emperipolesis usually are histiocytes, but other 
cell types may participate. Emperipolesis can also be found in some cancers. 
The exact mechanism for emperipolesis is not fully known but it is believed that 
the pathway of lizosom degradation mediated NK (“natural killer”) cells is crucial 
in this process. It was noted that NK cells use emperipolesis when leading tumor 
cells to programmed cell death. Process similar to emperipolesis, called entosis was 
also described, but with the different ultrastructural pathways and molecules in-
135
Rad 530. Medical Sciences, 44(2017) : 121-136
4th Scientific Symposium on Apoptosis and Neoplasms 
volved. Fate of the cells after process is done is one of the raised questions. Usually 
degradation of one cell is seen.
In some epithelial tumors of the kidney emperipoplesis was observed. In the last 
5 years an entity called biphasic squamoid-alveolar carcinoma of the kidney was 
described and it has characteristics of papillary renal cell carcinoma with emperi-
polesis in the near proximity of large cells. The significance of this process in the 
kidney tumors has not yet been fully clarified.
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Survivin is a member of the inhibitor of apoptosis (IAP) family. It is also involved 
in the regulation of cell division. Survivin is widely expressed in foetal tissues and 
in human cancers, but generally not in normal adult tissue. Apoptosis is the process 
of programmed cell death where senescent or damaged cells that are beyond repair 
are eliminated. It is a cascade of molecular events regulated by proteins that pro-
mote or prevent cell death. It is believed to be an important mechanism by which 
therapeutic chemotherapy and radiation therapy destroy cancer cells. Survivin is an 
anti-apoptotic protein that is overexpressed in most human cancers. Survivin regu-
lates the G2/M phase of the cell cycle by associating with mitotic spindle microtubu-
les, and it directly inhibits caspase-3 and caspase-7 activity. During tumorigenesis, 
survivin expression is inversely correlated with apoptosis inhibition and positively 
correlated with proliferation and angiogenesis. In our previous research, we ob-
served immunohistochemical results of survivin and the relation between survi-
vin and proliferative index Ki-67 in 50 cases of breast cancer in accordance with 
immunophenotype by St.Galen (2015g.). Survivin immunoreactivity was evaluated 
semiquantitatively according to the previous studies.  Nuclear and cytoplasmic tu-
mour cell immunoreactivities were separately assessed  at 40 magnification, and 
were given an arbitrary score as follows: 0(0-5% positive cells); 1(5–20%); 2(21–50%); 
